This inventor holds 2 USPTO granted patents and 1 published patent application and 5 EPO patents. Top assignee: Sanofi. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Michael Noble - Innovator in Medicament Dispensing Technology
Introduction
Michael Noble is a notable inventor based in Herts, GB. He has made significant contributions to the field of medicament dispensing technology. His innovative approach has led to the development of a unique injector device that enhances the efficiency and safety of medicament delivery.
Latest Patents
Michael holds a patent for an "Injector device having a braking arrangement." This device comprises an outer housing designed to receive a medicament container. It features a drive mechanism that dispenses the medicament from the container. The drive mechanism includes a plunger rod and a displacing member, which displaces the distal end of the plunger rod into the medicament container to dispense the medicament. Additionally, the device is equipped with a brake that slows the rate of displacement of the plunger rod under the force of the displacing member. This innovation is crucial for ensuring controlled and safe medicament delivery.
Career Highlights
Michael Noble is currently employed at Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to focus on developing advanced medical devices that improve patient care. His dedication to innovation in this field has positioned him as a key player in the industry.
Collaborations
Michael has collaborated with talented professionals such as Uwe Dasbach and Kai Scheinert. These partnerships have fostered a creative environment that encourages the development of groundbreaking medical technologies.
Conclusion
Michael Noble's contributions to medicament dispensing technology exemplify the impact of innovation in healthcare. His patented injector device represents a significant advancement in the field, showcasing his commitment to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
